A case of tocilizumab-refractory idiopathic multicentric Castleman's disease successfully treated with sirolimus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A case of tocilizumab-refractory idiopathic multicentric Castleman's disease successfully treated with sirolimus

Published:2021-12 Issue: Volume:233 Page:108887
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Sumiyoshi Remi,Koga Tomohiro,Furukawa Kaori,Umeda Masataka,Yamamoto Kazuko,Mori Ryoichi,Kawakami Atsushi

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference8 articles.

1. Localized mediastinal lymphnode hyperplasia resembling thymoma;Castleman;Cancer,1956

2. Multicentric giant lymph node hyperplasia. A hyperimmune syndrome with a rapidly progressive course;Bartoli;Am. J. Clin. Pathol.,1980

3. Castleman-Kojima Disease (TAFRO Syndrome) : A Novel Systemic Inflammatory Disease Characterized by a Constellation of Symptoms, Namely, Thrombocytopenia, Ascites (Anasarca), Microcytic Anemia, Myelofibrosis, Renal Dysfunction, and Organomegaly : A Status Report and Summary of Fukushima (6 June, 2012) and Nagoya Meetings (22 September, 2012)

4. Tentative diagnostic criteria and disease severity classification for Castleman disease: a report of the research group on Castleman disease in Japan;Fujimoto;Mod. Rheumatol.,2018

5. Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease;Fajgenbaum;J. Clin. Invest.,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunology and targeted therapy in Castleman disease;Expert Review of Clinical Immunology;2024-05-27

2. Biomarkers and Signaling Pathways Implicated in the Pathogenesis of Idiopathic Multicentric Castleman Disease/Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, Renal Insufficiency, and Organomegaly (TAFRO) Syndrome;Biomedicines;2024-05-21

3. Sirolimus is effective for refractory/relapsed idiopathic multicentric Castleman disease: A single-center, retrospective study;Annals of Hematology;2024-05-01

4. Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert Panel;HemaSphere;2023-05-23

5. Candidate biomarkers for idiopathic multicentric Castleman disease;Journal of Clinical and Experimental Hematopathology;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3